Stomach-comforting pharmaceutical composition and application thereof

Abstract

The invention discloses a stomach-comforting pharmaceutical composition and application thereof. The stomach-comforting pharmaceutical composition comprises the following materials in parts by weight: 5-7 parts of fried radix bupleuri, 9-11 parts of scutellaria baicalensis, 1-3 parts of oroxylum indicum, 14-16 parts of fried white paeony root, 9-11 parts of fried white atractylodes rhizome, 9-11 parts of fried fructus aurantii, 14-16 parts of poria cocos, 9-11 parts of processed pinellia tuber, 14-16 parts of dandelion, 1-3 parts of fructus amomi, 9-11 parts of Sichuan mangnolia officinalis, 9-11 parts of wrinkled giant hyssop, 9-11 parts of perilla stems, 9-11 parts of Thunberg fritillary bulb and 9-11 parts of bletilla striata. The stomach-comforting pharmaceutical composition disclosed by the invention is rigorous in component, integrally regulated from multiple layers, multiple links and multiple target points, remarkable in clinical curative effect for treating reflux esophagitis, obviously improves symptoms, can reduce pathogenetic condition relapse of a patient and can reduce dependence on a proton pump, and is free of toxic and side effect.

Description

technical field [0001] The invention relates to the technical field of drug combinations for treating stomach diseases, in particular to a stomach-relieving drug composition and its application. Background technique [0002] Reflux esophagus disease is a common and frequently-occurring disease of the digestive system, with an increasing incidence in the population. It is an inflammatory lesion of the esophagus caused by the reflux of the contents of the stomach and duodenum into the esophagus. Esophageal erosions and / or esophageal ulcers. Reflux esophagitis can occur in people of any age, and the incidence in adults increases with age. The global incidence has been on the rise in the past two decades. Middle-aged and elderly people, obesity, smoking, drinking, and high mental stress are high-risk groups for reflux esophagitis. The clinical manifestations of reflux esophagitis: 1. The severity of esophagitis has no correlation with reflux symptoms. Patients with reflux eso...

AI Technical Summary

Problems solved by technology

[0007] But above-mentioned three kinds of traditional Chinese medicines for the treatment of reflux esophagitis have reached certain drug effect in treatment, but drug effect stability is poor, and it is relatively difficult to the comprehensive quality control of medicine, and existing western medicine side effect is bigger, can't treat both symptoms and root causes simultaneously Therefore, it is necessary to study a drug for the treatment of reflux esophagitis that has good clinical efficacy, no side effects, and reduces the recurrence of the patient's condition and the dependence on proton pump inhibitors.

Images